Laparoscopic Adjustable Gastric Banding Reduces Subcutaneous Adipose Tissue and Blood Inflammation in Nondiabetic Morbidly Obese Individuals |
| |
Authors: | Laura Iaffaldano Carmela Nardelli Vincenzo Pilone Giuseppe Labruna Andreina Alfieri Donatella Montanaro Maddalena Ferrigno Maria Restituta Zeccolella Nicola Carlomagno Andrea Renda Alfonso Baldi Pietro Forestieri Lucia Sacchetti Pasqualina Buono |
| |
Affiliation: | 1. CEINGE-Biotecnologie Avanzate S.C.a R.L., Via G. Salvatore 486, 80145, Naples, Italy 2. Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, Via S. Pansini 5, 80131, Naples, Italy 3. Dipartimento di Medicina e Chirurgia, Università degli Studi di Salerno, Via Giovanni Paolo II 132, 84084, Fisciano, Salerno, Italy 4. IRCCS Fondazione SDN–Istituto di Ricerca Diagnostica e Nucleare, Via Gianturco 113, 80142, Naples, Italy 5. Dipartimento Scienze Motorie e del Benessere, Università degli Studi di Napoli Parthenope, Via Amm. F. Acton 38, 80133, Naples, Italy 6. Dipartimento di Scienze Biomediche Avanzate, Università degli Studi di Napoli Federico II, Via S. Pansini 5, 80131, Naples, Italy 7. Dipartimento di Scienze e Tecnologie Ambientali, Biologiche e Farmaceutiche, Seconda Università degli Studi di Napoli, Via Vivaldi 43, 81100, Caserta, Italy 8. Dipartimento di Medicina Clinica e Chirurgia, Università degli Studi di Napoli Federico II, Via S. Pansini 5, 80131, Naples, Italy
|
| |
Abstract: | Background Significant and sustained excess weight loss (EWL) appears to reduce the risk of obesity-related comorbidities (insulin resistance, hyperlipidemia, and inflammation), but this has been primarily shown in adult diabetic obese patients. We evaluated whether the EWL obtained 3 years after laparoscopic adjustable gastric banding (LAGB) improves the metabolic phenotype in nondiabetic morbidly obese (NDMO) individuals from south Italy. Methods Serum and subcutaneous adipose tissue (SAT) samples from 20 obese individuals (median BMI?=?41.5 kg/m2) before (T0) and after LAGB (T1) and from 10 controls (median BMI?=?22.8 kg/m2) were taken. Serum leptin, adiponectin, C reactive protein (CRP), and main analyte levels were evaluated by routine methods or immunoassay. In SAT, adipocyte size was measured by hematoxylin/eosin staining, cluster of differentiation 68 (CD68) macrophage infiltration marker by immunohistochemistry, and adiponectin, adiponectin receptors 1 and 2, and interleukin 6 (IL6) messenger RNAs by qRT-PCR. Results The average EWL was 66.7 %, and CRP, triglycerides, hepatic markers, leptin levels, homeostasis model assessment, and the leptin/adiponectin ratio were lower (p?0.05) at T1 than at T0. The expression of small adipocytes and adiponectin was increased (p?0.05), and inflammation markers (CD68 and IL6) decreased (p?0.05) at T1 vs. T0. At linear regression multivariate analysis, over 90 % (R 2?=?0.905) of EWL (dependent variable) was explained by CD68, adiponectinemia, triglyceridemia, CRP, and total protein levels. Conclusions The EWL obtained 3 years after LAGB resulted in an improvement of lipid metabolism and a reduction of inflammation in NDMO patients, thereby decreasing the risk of obesity-associated diseases. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|